About CULT Food Science

We are making cell-based foods part of everyday life.
The first publicly-traded company of its kind in North America, CULT Food Science is pioneering the investment and commercialization of cellular agriculture products to create a sustainable and ethical solution for the future of food.

What are we building?

CULT Food Science is focused on two specific areas: building food brands that are good for the world and investing into the most innovative cellular agriculture companies on the planet.

These two areas have a unique synergy.

By building food brands that are good for people and good for the world, we are obsessive about finding the best ingredients. To find the best ingredients, we scour the world looking for the companies who are using cellular agriculture to create food inputs that are slaughter free, net zero emissions and nutritionally sound.

When we find those companies, we invest in them. When we invest in them, we not only own equity in them, we are developing a partnership around ingredient supply.

We then take those ingredients and we get to work on building entirely new categories of food that are both delicious and ethically sound.

These new categories of food get tested, refined and iterated on through our product incubation studio until we feel they are ready to make an impact.

As we begin to bring this entirely new type of food product into the world, we create a virtuous cycle. It’s good for the consumer, good for the planet, good for animals, good for our portfolio companies and good for us.

We think of this as a complete cellular agriculture ecosystem. Harm free. Slaughter free. Environmentally friendly. Ready to eat and ready for the future.

That is what we are building.

Click to read more

Meet the team

Our leadership team has a diverse array of knowledge and hands-on expertise as founders, consumer product developers, and operating public companies.

Interested in joining our growing team? Check out our career opportunities.

Mitchell Scott
Chief Executive Officer
More about Mitchell Scott
Open/Close Icon

Mitchell Scott has been involved in the plant-based and cultivated food spaces for the past 8 years. He co-founded plant-based butchery The Very Good Butchers and oversaw its journey from a farmer's market stall to the top performing IPO (globally) of 2020, where at its peak, it achieved a market cap of almost $1B.

During his time there, The Very Good Butchers sold hundreds of thousands of boxes directly to consumers via their in-house ecommerce platform as well as on Amazon. They also established a retail presence in over 4000 retailers across North America with many stores carrying 10+ different products from the company. In addition, he launched their products into the U.K. and laid the groundwork for a European expansion. Much of this growth was spurred on by the passionate community of fans (150k+ across Facebook and Instagram) that was built up over the years.

Mitchell was able to successfully raise over $60M CAD for the company which helped fuel their growth and expansion efforts including impressive triple digit YOY revenue growth for three consecutive years (1M, 3M, 10M). He has a wealth of experience in building and scaling consumer facing brands and brings a growth mindset to everything he does.

Francis Rowe
CFO, Corporate Secretary
More about Francis Rowe
Open/Close Icon

Francis is a Chartered Professional Accountant and holds a Bachelor of Science degree from the University of Northern British Columbia. He has provided accounting and tax services to a wide range of business and personal clients. In addition, he currently serves as a Director and Chief Financial Officer for several public and private entities.

Advisory Team

We have brought together the brightest minds across synthetic biology, agriculture, biotechnology, cellular agriculture, and capital markets to guide our product development, validate our investments, and identify industry opportunities.

Mark Binns
Capital Markets Advisor
Open/Close Icon

Mr. Binns is a seasoned entrepreneur and public markets executive, highlighted by his former roles as CEO of Netcoins and BIGG Digital Assets (CSE: BIGG), in which he successfully navigated the public markets ecosystem, raised more than $50M in capital, and landed institutional research coverage. Mr. Binns also has deep relationships in the Canadian and US capital markets with investment bankers, stock brokers and investment advisors, family offices, high net worth individuals and investment funds.

Russell Starr
Strategic Advisor
Open/Close Icon

Mr. Starr is an executive, leader and entrepreneur with deep capital markets expertise and a track record of orchestrating transformative deals in disruptive industries. He has held numerous executive positions, including Head of Capital Markets at DeFi Technologies (CBOE: DEFI). Mr. Starr is also a seed investor in Echelon Wealth Partners and has built a robust network in the capital markets that will be a major asset for CULT as the company advances and scales its strategy of pioneering the commercialization of cultivated foods.

Dr. Anthony Marotta
Chief Scientific Officer & Chief Executive Officer
Peqish Health
Open/Close Icon

Dr. Anthony Marotta, Ph.D. is a serial entrepreneur and a proven scientific and clinical leader whom also has a very strong business and operational acumen which is key in delivering shareholder value. As part of his professional tenure, Marotta has co-founded companies including Augurex Life Sciences Corp and Peqish Group and has been a business and clinical advisor for various companies including DueNorth BioDev, Network Immunology and SignalChem Life Sciences Corp. During Marotta's eleven-year tenure at Augurex he was responsible for the development of the 14-3-3ç biomarker programs, and the successful approvals and launching of the blood tests in Canada, Europe, Australia and United States. At Peqish, Marotta has played a critical role in assisting the business in building out its "food as medicine" strategy and differentiating itself from other organizations in the food space. Marotta has also been key in assisting the Peqish team to operationalise business processes and achieve double digit profitability on EBIDTA. Prior to Augurex and Peqish, Marotta served as the Director of Business Development for Stressgen Bioreagents where he tactically grew the product portfolio by 30% through developing strategic collaborations. He also played a key role in training lab, sales and technical staff and was involved in several aspects of the day-to-day operations of the whole business. Marotta holds several patents, has co-authored, and presented at various international conferences, and has strong relationships with clinicians worldwide. Marotta completed his Ph.D. in Experimental Medicine at the University of British Columbia.

Dr. Sarah Dodd
EBVS® European Specialist
European College of Veterinary and Comparative Nutrition
Open/Close Icon

Dr. Dodd graduated from the veterinary science program at Massey University in New Zealand in 2016, after which she completed MSc and PhD degrees at the University of Guelph in Canada. In 2021, Dr. Dodd passed her certifying exam and was recognized as a diplomate of the European College of Veterinary and Comparative Nutrition by the European Board of Veterinary Specialists®. Dr. Dodd's research specializes in plant-based nutrition for companion animals and in clinical practice she predominantly formulates specialized diets for cats and dogs with complicated health conditions. In addition to her nutrition specialty, Dr. Dodd is also a practicing veterinarian and she enjoys working with farmed animal sanctuaries and dog and cat rescues.